These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7912103)

  • 1. Exercise tolerance in angina is improved by mivazerol--an alpha 2-adrenoceptor agonist.
    Wright RA; Decroly P; Kharkevitch T; Oliver MF
    Cardiovasc Drugs Ther; 1993 Dec; 7(6):929-34. PubMed ID: 7912103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an alpha(2) agonist (mivazerol) on limiting myocardial ischaemia in stable angina.
    Fox K; Dargie HJ; de Bono DP; Oliver MF; Wülfert E; Kharkevitch T
    Heart; 1999 Sep; 82(3):383-5. PubMed ID: 10455094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative sympatholysis. Beneficial effects of the alpha 2-adrenoceptor agonist mivazerol on hemodynamic stability and myocardial ischemia. McSPI--Europe Research Group.
    Anesthesiology; 1997 Feb; 86(2):346-63. PubMed ID: 9054253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
    Thadani U; Ezekowitz M; Fenney L; Chiang YK
    Circulation; 1994 Aug; 90(2):726-34. PubMed ID: 8044941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.
    Frishman WH; Pepine CJ; Weiss RJ; Baiker WM
    J Am Coll Cardiol; 1995 Aug; 26(2):305-12. PubMed ID: 7608428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial.
    Borer JS; Fox K; Jaillon P; Lerebours G;
    Circulation; 2003 Feb; 107(6):817-23. PubMed ID: 12591750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P; Broustet JP
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina.
    Holdright DR; Sparrow JL; Wright CL; Steiner J; Fox KM
    Cardiovasc Drugs Ther; 1994 Apr; 8(2):193-7. PubMed ID: 7918131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina.
    Chen JW; Lee WL; Hsu NW; Lin SJ; Ting CT; Wang SP; Chang MS
    Am J Cardiol; 1997 Jul; 80(1):32-8. PubMed ID: 9205016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
    Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects.
    Lam J; Chaitman BR; Crean P; Blum R; Waters DD
    J Am Coll Cardiol; 1985 Aug; 6(2):447-52. PubMed ID: 3894474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
    Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effects of perioperative continuous administration of mivazerol on early postoperative hemodynamics and plasma catecholamines after major surgery].
    Apitzsch H; Olthoff D; Thieme V; Vetter B; Wiegel M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2000 Aug; 35(8):515-22. PubMed ID: 10992963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mibefradil compared with amlodipine in suppressing exercise-induced and daily silent ischemia: results of a multicenter, placebo-controlled trial.
    Tzivoni D; Kadr H; Braat S; Rutsch W; Ramires JA; Kobrin I
    Circulation; 1997 Oct; 96(8):2557-64. PubMed ID: 9355894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris.
    Rousseau MF; Pouleur H; Cocco G; Wolff AA
    Am J Cardiol; 2005 Feb; 95(3):311-6. PubMed ID: 15670536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and antiischemic effects of intravenous elgodipine, a new dihydropyridine calcium channel blocker, in patients with chronic stable angina.
    Kuhn A; Carlsson J; Miketic S; Tebbe U
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):595-600. PubMed ID: 8547210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT).
    Oliver MF; Goldman L; Julian DG; Holme I
    Anesthesiology; 1999 Oct; 91(4):951-61. PubMed ID: 10519497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.